Related Experiment Video
Updated: Jul 6, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Oral anticoagulants and non-cardioembolic stroke prevention
Michael E Schachter1, Huyen A Tran, Sonia S Anand
1Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Abstract:
The use of anticoagulants for secondary prevention following non-cardioembolic ischemic stroke is controversial. This systematic review evaluates the safety and efficacy of oral anticoagulation compared with control and antiplatelet therapy.
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis III: Interprofessional Care
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Ischemic Stroke l: Introduction